Dr. Michniacki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
University of MichiganFellowship, Pediatric Hematology/Oncology, 2016 - 2019
University of ColoradoResidency, Pediatrics, 2013 - 2016
University of Michigan Medical SchoolClass of 2013
Certifications & Licensure
MI State Medical License 2016 - 2026
CO State Medical License 2013 - 2016- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Roles: Contact
Publications & Presentations
PubMed
- 6 citationsImmune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.Thomas F. Michniacki, Sung Won Choi, Daniel Peltier
Handbook of Experimental Pharmacology. 2021-10-10 - 42 citationsHematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.Thomas F. Michniacki, Mark C. Hannibal, Charles W. Ross, David Frame, Adam S. DuVall
Journal of Clinical Immunology. 2018-02-01 - 5 citationsIn cis "benign" SOCS1 variants linked to enhanced interferon signaling and autoimmunity.Yan Du, Kailey E Brodeur, Evan Hsu, Liang Chen, Qian Chen
Journal of Autoimmunity. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
